Valeant Pharmaceuticals still has plenty of supporters despite the media storm surrounding the company and its businesses practices.
Last night it emerged that Bill Ackman, one of Valeant's most staunch supporters, has upped Pershing Square’s stake in Valeant to 9.9% of the company’s outstanding shares -- a near 70% increase in Pershing's holding before recent declines.
Sign up now and get our in-depth FREE e-books on famous investors like Klarman, Dalio, Schloss, Munger Rupert is a committed value investor and regularly writes and invests following the principles set out by Benjamin Graham. He is the editor and co-owner of Hidden Value Stocks, a quarterly investment newsletter aimed at institutional investors. Rupert owns shares in Berkshire Hathaway. Rupert holds qualifications from the Chartered Institute For Securities & Investment and the CFA Society of the UK. Rupert covers everything value investing for ValueWalk
Top Business Moguls Share Best Advice by Amy Chen via LinkedIn Pulse This morning LinkedIn Pulse launched their “Best Advice” package where top executives and business moguls share the best... read more
This is part two of a four-part interview with Abhay Deshpande of Centerstone Investors. The interview is part of ValueWalk’s Value Fund Interview Series. Throughout this series, we are publishing... read more
DISH Network Corp (NASDAQ:DISH) dropped out of the bidding to buy mobile phone carrier Sprint Nextel Corporation (NYSE:S), paving the way for Sprint Nextel Corporation (NYSE:S)’s acquisition by SoftBank... read more
The high yield new issue market came roaring back to life last week according to Bank of America’s credit strategists Michael Contopoulos and team, but despite record levels of... read more
Hedge weekly After losing a staggering 49.5% for his investors last year, vocal hedge fund manager Crispin Odey must have been hoping for a good start to the New Year.... read more
The International Consortium of Investigative Journalists has just released a trove of leaked tax documents detailing the deals made between PricewaterhouseCoopers and the Luxembourg Ministry of Finance on behalf... read more
Popular shorts have the tendency to do more harm to bearish hedge funds than any good. The much-feared short squeeze is common in companies which have an exorbitant amount... read more
After months of campaigning, UK has finally decided to leave the European Union. A risk-off mentality has now gripped financial markets around the world as investors and traders wait... read more
Alluvial Fund commentary for the second quarter ended June 30, 2020. Q2 2020 hedge fund letters, conferences and more Alluvial Fund rose 14.8% in the second quarter, recouping most of the... read more
Every afternoon ValueWalk provides an update on global market levels, economic news, and hedge fund news. Market Levels * US: Dow: 13092.69 (0.36%), S&P 500: 1397.64 (0.35%), NASDAQ: 3067.88 (0.15%) * Europe:... read more
The top investors are reading ValuewalkPremium.
